Email from IPIX just received: Scientific Rationa
Post# of 72444
(Total Views: 385)
Posted On: 02/28/2020 2:36:16 PM
Email from IPIX just received:
Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.
Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.
The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.
Download now
Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.
Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.
The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.
Download now
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼